Skip to content

Clinical trials

Phase 1 Carcinoma, Hepatocellular trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1 Country / region: Australia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20161
20172
20191
20201
20211
20232
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed4
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Exelixis2
AstraZeneca1
Huahui Health1
Incyte Corporation1
MacroGenics1
Mateon Therapeutics1
Myeloid Therapeutics1
OncoC4, Inc.1
SAPU NANO (US) LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular15
Carcinoma, Renal Cell8
Colorectal Neoplasms8
Carcinoma, Non-Small-Cell Lung7
Squamous Cell Carcinoma of Head and Neck6
Neoplasm Metastasis5
Neoplasms5
Ovarian Neoplasms5
Small Cell Lung Carcinoma5
Stomach Neoplasms5

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.